These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15225705)

  • 21. N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.
    Deur C; Agrawal AK; Baum H; Booth J; Bove S; Brieland J; Bunker A; Connolly C; Cornicelli J; Dumin J; Finzel B; Gan X; Guppy S; Kamilar G; Kilgore K; Lee P; Loi CM; Lou Z; Morris M; Philippe L; Przybranowski S; Riley F; Samas B; Sanchez B; Tecle H; Wang Z; Welch K; Wilson M; Yates K
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4599-603. PubMed ID: 17562362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
    McIntyre CJ; McCauley JA; Bednar B; Bednar RA; Butcher JW; Claremon DA; Cunningham ME; Freidinger RM; Gaul SL; Homnick CF; Koblan KS; Mosser SD; Romano JJ; Liverton NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5132-5. PubMed ID: 19648007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
    Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
    J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease.
    Nash JE; Ravenscroft P; McGuire S; Crossman AR; Menniti FS; Brotchie JM
    Exp Neurol; 2004 Aug; 188(2):471-9. PubMed ID: 15246846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
    Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons.
    Noh J; Lee ES; Chung JM
    J Neurochem; 2009 Jun; 109(5):1261-71. PubMed ID: 19302475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational studies to discover a new NR2B/NMDA receptor antagonist and evaluation of pharmacological profile.
    Gitto R; De Luca L; Ferro S; Occhiuto F; Samperi S; De Sarro G; Russo E; Ciranna L; Costa L; Chimirri A
    ChemMedChem; 2008 Oct; 3(10):1539-48. PubMed ID: 18767069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
    Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
    Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived neurotrophic factor acutely enhances tyrosine phosphorylation of the AMPA receptor subunit GluR1 via NMDA receptor-dependent mechanisms.
    Wu K; Len GW; McAuliffe G; Ma C; Tai JP; Xu F; Black IB
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):178-86. PubMed ID: 15519688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
    Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
    Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.
    Varano F; Catarzi D; Colotta V; Calabri FR; Lenzi O; Filacchioni G; Galli A; Costagli C; Deflorian F; Moro S
    Bioorg Med Chem; 2005 Oct; 13(19):5536-49. PubMed ID: 16087341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors.
    Tamiz AP; Whittemore ER; Woodward RM; Upasani RB; Keana JF
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1619-24. PubMed ID: 10386947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain.
    Faucard R; Armand V; Héron A; Cochois V; Schwartz JC; Arrang JM
    J Neurochem; 2006 Sep; 98(5):1487-96. PubMed ID: 16923161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists.
    Poschenrieder H; Stachel HD; Höfner G; Mayer P
    Eur J Med Chem; 2005 Apr; 40(4):391-400. PubMed ID: 15804538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors.
    von Engelhardt J; Coserea I; Pawlak V; Fuchs EC; Köhr G; Seeburg PH; Monyer H
    Neuropharmacology; 2007 Jul; 53(1):10-7. PubMed ID: 17570444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards NR2B receptor selective imaging agents for PET-synthesis and evaluation of N-[11C]-(2-methoxy)benzyl (E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidine.
    Arstad E; Platzer S; Berthele A; Pilowsky LS; Luthra SK; Wester HJ; Henriksen G
    Bioorg Med Chem; 2006 Sep; 14(18):6307-13. PubMed ID: 16777419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.